e-learning
resources
Munich 2006
Monday 04.09.2006
Airway biology and pathology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Human α-defensin as a biosensor of interstitial lung diseases. An
ex-vivo
study
G. Paone, F. Carbone, G. Lucantoni, G. Galluccio, E. Li Bianchi, P. Di Giacomo, P. Regimenti, A. Perrone, G. Munafo‘, G. Schmid (Rome, Italy)
Source:
Annual Congress 2006 - Airway biology and pathology
Session:
Airway biology and pathology
Session type:
Electronic Poster Discussion
Number:
2018
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Paone, F. Carbone, G. Lucantoni, G. Galluccio, E. Li Bianchi, P. Di Giacomo, P. Regimenti, A. Perrone, G. Munafo‘, G. Schmid (Rome, Italy). Human α-defensin as a biosensor of interstitial lung diseases. An
ex-vivo
study. Eur Respir J 2006; 28: Suppl. 50, 2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Computed-tomography-based radiomics features for staging of interstitial lung disease – transferability from experimental to human lung fibrosis - a proof-of-concept study
Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update
Year: 2019
Epidemiology of interstitial lung diseases. The RENIA study
Source: Eur Respir J 2001; 18: Suppl. 33, 440s
Year: 2001
Human lung scaffolds to model lung disease and tissue regeneration
Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration
Year: 2018
B-cell infiltration varies among patients with interstitial lung diseases
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis, non-specific interstitial pneumonia and human donor lungs
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Volumetric texture analysis in the characterisation of interstitial lung diseases in lung transplant patients.
Source: International Congress 2017 – Various imaging modalities for different lung diseases
Year: 2017
Cultivating bronchial epithelial cells collected through bronchoscopic microsampling in patients with interstitial lung disease
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
Effect of pirfenidone (PFD) on cytokine/chemokine release from alveolar macrophages (AMs) in interstitial lung diseases (ILD): Preliminary results
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013
Modeling human pulmonary inflammatory diseases and therapeutic responses in a microfluidic lung airway-on-a-chip
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Development of assays to evaluate inflammasomes’ activity in the peripheral blood and in alveolar macrophages in fibrotic lung diseases
Source: International Congress 2018 – Back to basics and translational research in idiopathic interstitial pneumonias
Year: 2018
Bacterial culture results in patients with interstitial lung diseases
Source: Eur Respir J 2003; 22: Suppl. 45, 255s
Year: 2003
Role of imaging in progressive-fibrosing interstitial lung diseases
Source: Eur Respir Rev, 27 (150) 180073; 10.1183/16000617.0073-2018
Year: 2018
B cell activating factor belonging to the TNF family might be a useful biomarker in interstitial lung diseases associated with connective tissue diseases
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Pattern of diffusion disturbance in patients with interstitial lung diseases (ILDs)
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016
Lung ultrasound in the evaluation of interstitial lung diseases in the course of connective tissue diseases
Source: International Congress 2017 – Rare diseases
Year: 2017
Telemetric observation of the course and treatment effects of selected interstitial lung diseases associated with connective tissue diseases (CTD-ILD) – protocol presentation
Source: Virtual Congress 2020 – Natural history and management of interstitial lung diseases of known cause
Year: 2020
Interstitial lung diseases associated with lung cancer
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016
Efficacy of functionalized-imatinib loaded gold nanoparticles on lung fibroblastoid cells from systemic sclerosis patients
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Lung ultrasound in children with interstitial lung disease: a pilot study.
Source: Virtual Congress 2020 – Tip the hat to paediatric bronchology
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept